What is the next best step in managing a female with stage 4 chronic kidney disease, hypertension, anemia, and macular degeneration who now has persistent pallor, non‑productive cough, and body aches despite a negative chest X‑ray?

Next Best Step: Evaluate for Anemia and Consider Underlying Causes

The next best course of action is to obtain a complete blood count (CBC) with differential and reticulocyte count to assess the severity and type of anemia, followed by targeted workup based on those results, while simultaneously evaluating for common causes of persistent non-productive cough including upper airway cough syndrome, asthma, and gastroesophageal reflux disease. 1, 2

Immediate Priority: Address the Pallor and Known Anemia

• Pallor in a patient with known anemia and stage 4 CKD requires urgent laboratory assessment to determine if the anemia has worsened and whether it is contributing to her symptoms (body aches, fatigue). 3

• Stage 4 CKD patients commonly develop worsening anemia of chronic kidney disease, which can manifest as pallor, fatigue, and generalized body aches—symptoms that overlap with her current presentation.

• Body aches in the context of worsening anemia may reflect tissue hypoxia rather than an infectious or inflammatory process, especially given the negative COVID test and chest X-ray.

Chronic Cough Evaluation Framework

The chest X-ray has appropriately been obtained as first-line imaging

• Chest radiography is recommended by the American College of Chest Physicians, British Thoracic Society, and American College of Radiology as the mandatory first imaging test for all patients with chronic cough (>8 weeks duration). 1, 2

• The negative chest X-ray effectively rules out community-acquired pneumonia, given normal vital signs and the absence of focal consolidation findings. 3

• However, chest X-ray has only 64% negative predictive value for pulmonary causes of chronic cough, and up to 34-36% of patients with normal chest X-rays have significant CT findings. 2

Sequential empiric treatment approach is indicated

Since the chest X-ray is negative and there are no red flags (no hemoptysis, no significant dyspnea, no unintentional weight loss, no hoarseness), the next step is sequential empiric treatment for the three most common causes of chronic cough: 1, 2, 4

1. Upper airway cough syndrome (UACS)/post-nasal drip (accounts for ~44% of chronic cough cases) 2

   • Trial of first-generation antihistamine/decongestant combination
   • Intranasal corticosteroids if rhinitis features present

2. Asthma/cough-variant asthma 1, 5, 4

   • Consider bronchodilator trial
   • May require bronchial provocation testing if initial treatment fails

3. Gastroesophageal reflux disease (GERD) 1, 5, 4

   • However, note that in the absence of GI symptoms, proton pump inhibitor therapy is not recommended for unexplained chronic cough per CHEST guidelines 6

Critical Considerations in This Patient

Medication review is essential

• Review all medications for ACE inhibitors, which cause chronic cough with median resolution time of 26 days after discontinuation. 2

• ACE inhibitors are commonly prescribed for hypertension and CKD, making this a high-yield consideration in this patient.

When to consider advanced imaging

High-resolution CT (HRCT) should be reserved for: 1, 2

• Failure of sequential empiric treatment for all three common causes
• Presence of red flags (hemoptysis, smoker >45 years, prominent dyspnea, hoarseness, systemic symptoms, recurrent pneumonia)
• Suspicion for bronchiectasis (chronic productive cough with large sputum volume >30 mL/day, recurrent infections) 3

This patient does NOT currently meet criteria for HRCT given the non-productive nature of her cough, absence of red flags, and lack of empiric treatment trials. 1, 2

Malignancy screening considerations

• In patients with chronic cough and normal chest X-ray, lung cancer prevalence is approximately 1-2%, and malignancy can be missed on plain radiography. 2

• However, this patient has no smoking history and no red flags, making immediate CT less urgent than in a smoker >45 years with new or changed cough. 1

Practical Algorithm for This Patient

1. Obtain CBC with differential and reticulocyte count to assess anemia severity and guide management
2. Review medication list for ACE inhibitors and discontinue if present 2
3. Initiate empiric trial for upper airway cough syndrome (first-line given high prevalence) 2, 4
4. Reassess in 2-4 weeks:
   • If cough improves, continue current management
   • If cough persists, proceed to next empiric trial (asthma treatment)
   • If cough persists after all three empiric trials, consider HRCT 1, 2

Common Pitfalls to Avoid

• Do not order HRCT prematurely before completing empiric treatment trials in the absence of red flags, as this increases cost without improving outcomes in most cases. 1, 2

• Do not attribute all symptoms to the cough alone—pallor and body aches may reflect worsening anemia requiring separate intervention.

• Do not prescribe PPI empirically for cough in the absence of GI symptoms, as CHEST guidelines recommend against this practice. 6

• Do not rely on physical examination alone to rule out serious causes; systematic empiric trials are required when initial workup is negative. 1, 4